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Abstract
Background: The inclusion of Magnesium Sulphate (MgSO4) as a gold standard in the treatment of eclampsia has
substantially reduced incidences of repeated fits, eclamptic morbidity and deaths. However, despite treatment with
MgSO4, a proportion of patients need extra medical/nursing attention and prolonged stay in the intensive care
unit (ICU). The literature on the underlying factors for the need of extra care in the MgSO4 era is lacking. This
study sought to establish predictors of extra care in ICU among eclamptic patients after treatment with MgSO4 at
Muhimbili National Hospital (MNH).
Methods: Data were obtained from hospital records of eclamptic patients who were admitted at MNH and treated
with MgSO4 from January 1
st to December 31
st, 2008. Based on set criteria, patients who needed extra care were
identified. Analysis was performed using PASW statistics 18 whereby frequencies, cross-tabulations, bivariate and
multiple logistic regressions were performed.
Results: A total of 366 eclamptic patients were admitted and treated with MgSO4 at MNH during a 12 month
study period in 2008. Most of these (76%) were referred from district hospitals and132 (36%) met the criteria for
extra care in ICU. After adjusting for other variables, the risk of extra care in ICU for patients who were admitted
with altered consciousness was double (OR = 2.3; 95% CI: 1.3-4.0) that of the ones admitted in alert state. The risk
or need of extra care increased by increasing time to delivery and was doubled (OR = 2.0; 95% CI:1.1-3.7) if it was
between 12 and 24 hours and tenfold elevated (OR = 10.0; 95% CI:4.3-23.6) if beyond 24 hours as compared to
when time to delivery was less than 12 hours.
Abdominal delivery was also independently associated with increased risk compared to vaginal delivery (OR = 2.5;
95%CI: 1.4-4.5). The type of referral and number of fits were associated with extra care in ICU but this association
was wholly explained by the clinical status of the patient on admission to MNH and prolonged time lag to
delivery.
Conclusion: We concluded that even with MgSO4 used as the gold standard in the treatment of eclampsia,
effective pre-referral care and expedited delivery were crucial in minimizing the need for extra care in ICU.
Background
Eclampsia is a serious obstetric complication which is
diagnosed when a woman with signs of pre-eclampsia
develops convulsions attributable to the disease [1-3].
Eclampsia is known to complicate 1 in 2000 deliveries
in the developed countries and between 1 in 100 and 1
in 1700 in the developing countries thus contributing
significantly to the global burden of maternal morbidity
and mortality [2-8]. Globally, eclampsia alone accounts
for 10% of all maternal deaths [8]. The importance of
eclampsia as a cause of severe morbidity is reflected by
its inclusion as an indicator in most international mea-
sures for severe acute maternal morbidity [9]. At
M u h i m b i l iN a t i o n a lH o s p i t a l( M N H ) ,f o rm a n yy e a r s
eclampsia has remained amongst the top 3 causes of
maternal mortality and an important cause of maternal
morbidity [10,11].
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two decades with a wide acceptance and use of Magne-
sium Sulphate (MgSO4) as the first drug of choice for
the control and prevention of eclamptic fits [2,3,12,13].
According to clinical trial reports, MgSO4 is superior to
other drugs that were traditionally used to control
eclamptic fits such as phenytoin, nimodipine and diaze-
pam [14-16]. In the multinational collaborative eclamp-
sia trial, MgSO4 reduced the risk of recurrent seizures
in eclamptic women by 52% when compared to diaze-
pam and by 67% when compared to phenytoin [17]. The
publication of these clinical trials significantly increased
the acceptance and use of MgSO4 in the treatment of
eclampsia [2,3,7,13,18]. In Tanzania, MgSO4 is currently
recognized and included in the essential drug list and
for over a decade it has completely replaced Diazepam,
phenytoin and lytic cocktail for the management of
eclampsia at MNH.
The benefits of MgSO4 use in treating eclampsia are
not confined to its effectiveness in controlling and pre-
venting eclamptic fits. Studies also show that the use of
this drug could further reduce maternal morbidity and
mortality. In Nigeria, a study at a tertiary hospital before
and after the introduction of MgSO4 reported case spe-
cific maternal death reduction from 39.4% to 15% [13].
A similar significant reduction in maternal deaths is
reported in Bangladesh [2,3]. Although the majority of
eclamptic patients generally recovers quickly and is dis-
charged within a week, about 20-35% remains in hospi-
tal for longer periods or suffer added complications that
call for extra attention [2,3,19].
The need for extra interventions and prolonged peri-
ods of medical/nursing attention among MgSO4 treated
eclampsia patients is of great importance particularly in
some developing countries like Tanzania where the
number of eclampsia cases is relatively high but the
resources are limited [2,3,6,8,10,11]. Although few stu-
dies have described outcomes of MgSO4 treatment in
terms of maternal deaths and associated factors [2,3] the
literature on the need and risk factors for extra care
among MgSO4 managed eclamptic patients is lacking.
This study describes the outcome of MgSO4 treated
patients in terms of need for extra care in Intensive
C a r eU n i t( I C U )a tM N Ha n df a c t o r st h a tp r e d i c tt h i s
need. Our results are expected to set a baseline for
future evaluation and improvement of eclampsia man-
agement at MNH.
Methods
Study settings
This hospital based study consisted of an analysis per-
formed on hospital records of a cohort of mothers who
were diagnosed to be eclamptic and who were admitted
at MNH and treated with MgSO4 from January 1
st to
December 31
st, 2008. MNH is the biggest consultant
hospital in the United Republic of Tanzania being situ-
ated in Dar es Salaam, the country’s largest city. Accord-
ing to the 2002 national population census, the city has
a total population of 3.4 million with an annual growth
rate of 4.3%. The maternity unit at MNH is affiliated to
the department of obstetrics and gynecology and
receives referred pregnant and postpartum mothers
from Dar es Salaam district hospitals as well as other
hospitals from within the city. Occasionally it receives
mothers from nearby regions. About 40 women deliver
at this unit each day. The MNH also serves as teaching
hospital for the Muhimbili University of Health and
Allied Sciences (MUHAS) which is public and the lar-
gest medical university in the country. This study was
ethically approved by the MUHAS ethical committee
and permitted by MNH.
Care of Eclamptic mothers at MNH
Eclampsia patients who are admitted at MNH come
with their antenatal cards and a referral note. They are
initially registered in the hospital’s electronic database
which registers their demographic information, referral
details and the admitting ward. The patients are then
transferred to a special 10 bed ICU where more details
are extracted and entered in a ward’s register book.
Maternal socio-demographic information is detailed in
the antenatal card, referral note and patient’s case note
all of which are retained by the hospital after discharge.
Care in the ICU at MNH is offered by doctors and
nurses who are trained in managing eclampsia according
to the existing protocol. There is always a rotating spe-
cialist in charge of the ward who conducts at least two
rounds daily. Any new patient is attended by a resident
doctor and the specialist on duty within one hour.
Drugs are administered by the nurses who also provide
nursing care to the patients. The usual management
protocol for eclamptic patients includes intravenous
MgSO4 to prevent and control eclamptic fits. A loading
dose of 4 g is given slowly intravenously (over 5-10 min-
utes) followed by a maintenance dose of 1 g hourly for
24 hours (counted from the last fit or delivery). Rapid
control of blood pressure is achieved by a slow intrave-
nous Hydrallazine (10 mg) repeated 20-30 minutes to
control the diastolic blood pressure between 90-100
mmHg. Long term control of blood pressure is achieved
with Methyl dopa. As part of routine care, delivery
should be achieved within 12 hours after admission.
Induction of labor if necessary is achieved by vaginal
Misoprostol or Oxytocin. Any divergence from this pro-
tocol is individualized and discussed with a specialist.
Vital signs are checked and recorded on a special
sheet half hourly. Number of fits, deep tendon reflexes,
urinary protein levels, medication and hourly urine
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ery details are recorded on the partogram. Mothers who
have delivered and who show good progress in terms of
control of fits, improved level of consciousness,
improved vital signs including the blood pressure are
usually transferred to postnatal ward after completion of
a maintenance dose of MgSO4. The decision to transfer
a patient to an ordinary postnatal ward is reached based
on the specialist’s opinion during a ward round and
after documentation in the case note. The usual dura-
tion of stay in ICU is 48-72 hours regardless of the
mode of delivery.
Data sources
We reviewed hospital admission electronic records, ward
admission record book, case notes, partogram records,
antenatal cards, and patient care records for all patients
admitted to ICU from January 1
st to December 31
st,
2008. A pilot study was conducted at MNH for two
months in order to improve our checklist variables and
establishing the optimal patient stay in ICU (which was
48-72 hours).
Data analysis
Data were entered in Epi Info 6 program and cleaned.
The software used for analysis was PASW Statistics ver-
sion 18. In this analysis, parity referred to the number
of pregnancies delivered at or after the gestation of 28
weeks excluding the current pregnancy/delivery. The
type of referral refers to whether the woman was
admitted at MNH before the first fit, or was received
from any of the district hospitals, private hospitals or
came directly from home. Time taken to delivery was
counted from the time the woman was admitted at the
referring hospital after fitting or after she developed a fit
for the first time while admitted. The criteria for need
of extra care in ICU consisted of the presence of any of
the following: 1). admission in the ICU beyond 3 days
2). Insertion of nasogastric tube (NGT) 3). Need for
resuscitation drugs (such as Calcium gluconate, lasix,
adrenaline, hydrocortisone, Oxygen etc) and 4). Need
for physiotherapy.
Bivariate logistic regression analysis was conducted to
assess the association between variables that character-
ized each patient and the need for extra care in ICU.
The dependent variable was dichotomized into 0 = No
need for extra care and 1 = There is need for extra care.
All variables with significant p-values (p < 0.05) in the
bivariate analysis were included in the multivariate ana-
lysis to assess how independently each variable predicted
the need for extra care. In the same model, other vari-
ables that did not reach a statistical significance level on
bivariate analysis but were considered clinically impor-
tant based on experience were also added. Odds ratios
(OR) and 95% confidence intervals (CI) were calculated
to estimate the risks for extra care in the study
population.
Results
During the study period, 366 mothers with a diagnosis
of eclampsia were admitted to ICU and treated with
MgSO4. Among them, there were 18 (4.9%) maternal
deaths. Eclamptic mothers were mostly younger than
25 years (68.6%), nulliporous (55.2%), referred from
district hospitals (75.7%) and not in labor (73.8%). A
total of 75 mothers had incomplete data particularly in
terms of gestation age and intrapartum events, hence
were excluded in some of the calculations as indicated
in Table 1.These 75 mothers, however, were compar-
able with the rest in terms of age distribution (mean
24 Vs 23.4 years), parity (para < 3 constituted 94% ver-
sus 93%) and need for extra-care in ICU (38% versus
37%).
Overall, 132 (36%) eclamptic mothers needed extra-
care in ICU. A typical candidate for extra care in ICU
was a parous woman, older than 24 years, referred from
a district or private hospital, not alert on admission to
MNH and carrying a pre-term pregnancy (Table 1).
The proportion of patients who developed more than
two fits before admission to ICU was 12.6% for mothers
who fitted for the first time while admitted at MNH,
36.4% for mothers who were admitted directly from
home, 41.9% of admissions from district hospitals and
55.1% from private hospitals. Prolonged admission
longer than 3 days was the most frequent indicator
(33%) of the need for extra care in ICU followed by the
use of resuscitation medications (13%) as illustrated in
Table 2.
On bivariate logistic regression analysis, six variables
including the type of referral, number of fits, state of
consciousness on admission, time to delivery, and mode
of delivery and gestation age were significantly asso-
ciated with need for extra care (Table 3). Variables that
were not significantly associated with need for extra
care included maternal age (p = 0.67), parity (p = 0.55),
marital status (p = 0.43), Hb level (p = 0.51), and timing
of first fit in relation to onset of labor (p = 0.25).
In a multivariate analysis, all the variables noted to be
significantly associated with the need for extra care in
ICU on the bivariate analysis were entered in the model.
As can be seen in Table 3, after adjusting for other vari-
ables, the patient’s state of consciousness on admission,
time taken to delivery, mode of delivery and gestation
age independently predicted the need for extra care in
ICU. The importance of the type of referral which was
seen on bivariate analysis was contingent to the patient’s
condition on admission, time taken to delivery and
mode of delivery. Likewise the state of consciousness
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predicting the need for extra care in ICU.
Discussion
The general results of this study show that a typical
eclamptic patient at MNH was younger than 24 years,
nulliporous at the gestational age above 32 weeks and
referral from a district hospital. Three quarters of
eclamptic mothers were referred after fitting twice or
more and nearly two thirds of all eclamptic mothers
were admitted with altered consciousness. Late referral
of eclamptic patients to MNH can result in increased
Table 1 Characteristics of eclamptic patients who were admitted at Muhimbili National Hospital in 2008
Characteristics Total Needed Extra care n (%) Not needed extra care. n (%)
Age group (years)
≤ 19 101 36 (35.6) 65 (64.4)
20-24 150 50 (33.3) 100 (66.7)
25-29 64 27 (42.2) 37 (57.8)
≥30 51 19 37.7) 32 (62.7)
Parity
0 202 69 (34.2) 133 (65.8)
1-2 137 51 (37.,2) 86 (62.8)
≥3 27 12 (44.4) 15 (55.6)
Marital status
Single 31 13 (41.9) 18 (58.1)
Married 161 62 (38.5) 99 (61.5)
Unspecified 174 57 (32.8) 117 (67.2)
Type of referral
Within MNH 32 6 (18.8) 26 (81.2)
Private hospitals 29 17 (58.6) 12 (41.4)
District Hospitals 277 103 (37.2) 174 (62.8)
Home 28 6 (21.4) 22 (78.6)
Timing of first fit
Antepartum 270 104 (38.5) 166 (61.5)
Intrapartum 25 8 (32.0) 17 (68.0)
Postpartum 71 20 (28.2) 51 (71.8)
Number of fits
1 94 26 (27.7) 68 (72.3)
2 123 40 (32.5) 83 (67.5)
≥3 149 66 (44.3) 83(55.7)
State of consciousness
Alert 199 56 (28.1) 143 (71.9)
Altered 167 76 (45.5) 91 (54.5)
Gestation age*
≤32 weeks 63 33 (52.4) 30 (47.6)
33-36 103 39 (37.9) 64 (62.1)
≥37 129 40 (31.0) 89 (69.0)
Last Hb level (g/dl)
> 8.5 313 115 (36.7) 198 (63.3)
≤8.5 53 17 (32.1) 36 (67.9)
Time taken to delivery†
≤12 166 40 (24.1) 126 (75.9)
12:01-24.00 82 35(42.7) 47 (57.3)
≥24.01 43 33 (76.7) 10 (23.3)
Mode of delivery
Vaginal 221 70 (31.7) 151 (68.3)
Abdominal 145 62 (42.8) 83 (57.2)
* Gestation age not known in 71 cases; † Labor duration for 75 deliveries not obtained
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where in the developing countries [2,3,7,8,13,19] and
previously at the same institution [11]. Moreover, the
current study was conducted in the context of low pre-
valence of provision of parenteral anticonvulsants
among health facilities in Tanzania. According to a
national survey report [20], only 3% of health centres
and 57% of hospitals provide parenteral anticonvulsants
for pre-eclampsia/eclampsia treatment. This is in con-
trary to the Ministry of Health and Social Welfare policy
which requires all health centres and hospitals that con-
duct deliveries to provide parenteral anticonvulsants for
the treatment of pre-eclampsia/eclampsia [20].
According to our results, there are two major reasons
to doubt the effectiveness of pre-referral management of
eclampsia. Firstly, patients who were referred from pri-
vate and district hospitals suffered disproportionately
from repeated fits than those who came directly to
MNH from home, implying that measures to prevent
repeated fits were not effectively instituted at these hos-
pitals. Secondly, we found a tendency towards increased
need for extra care in ICU for patients who arrived at
MNH after being cared at other hospitals in contrast to
those who came directly from home. For example, an
unadjusted risk for extra care in ICU was more than
five times if the patient was referred from a private hos-
pital. These discrepancies cannot be explained by the
difference in physical accessibility to health facilities
since all the district hospitals and most private hospitals
are situated within 5-10 kilometres from MNH. Thus
p a t i e n t sw h oc a m ed i r e c t l yt oM N Hi nn ow a yh a da
better access to health facility than the rest. In the con-
trary, mothers who attend private hospitals can be
assumed to stand a better chance of reporting early to
health facilities due to their better economic and social
privileges. However, although our arguments are rein-
forced by the evidence of low prevalence of provision of
parenteral anticonvulsants among health facilities in
Tanzania [20], we cannot dismiss the possibility that dis-
trict and private hospital referrals were biased towards
complicated cases of eclampsia. Future studies should
focus on quality of care of eclamptic patients at these
lower level health facilities.
More than a third of eclamptic patients needed extra
care in ICU. These mothers because of their severe
acute morbidities demanded extra medical and nursing
attention and prolonged stay in ICU. Apart from the
morbidity it causes, the demand for extra care in ICU
can be interpreted into more costs and limit of space in
such a busy ICU. It was therefore imperative to under-
stand factors associated with increased demand for extra
care in ICU. We found that overall six factors were
associated with the demand for extra care including the
health facility where the patient came from, number of
fits, state of consciousness on admission, duration taken
to delivery, mode of delivery and the gestation age.
Nevertheless, the importance of the health facility where
the patient came from, and the number of fits were con-
tingent on the other four factors on multivariate analy-
sis. This indicates it is the effectiveness of care given to
eclamptic patients rather than the place where this care
is provided that better predicts the need for extra care
in ICU.
Eclampsia require prompt and adequate care if severe
complications and mortalities have to be prevented. Pro-
vision of MgSO4 immediately after the first fit is the
best available means to control and prevent further
eclamptic fits and to retain the patient in a good state
of consciousness [12]. Studies indicate that provision of
even a single loading dose of 14 g MgSO4 is enough to
prevent eclamptic fits in the majority [19] but treatment
with MgSO4 in late cases may not improve survival [2].
Thus, a single loading dose of MgSO4 can be the mini-
mum recommendation for pre-referral care of eclamptic
patients in Tanzania.
As an important component of eclampsia manage-
ment, it is recommended to terminate pregnancy once
the patient is stabilized [7]. According to WHO, it is
recommended that termination of pregnancy should be
completed within 12 hours once the patient develops
eclamptic fits. Some institutions or individuals have
become overconfident with MgSO4 and delayed delivery
of babies is emerging [2]. In the current study, only 57%
of cases delivery was completed in 12 hours after admis-
sion. In 15% of the cases, delivery was completed longer
than 24 hours. Nevertheless, our results indicate pro-
gressive increase in the risk for extra care in ICU for
mothers who were undelivered in less than 12 hours
Table 2 Incidence of extra care indicators among
eclamptic mothers at Muhimbili National Hospital
Indicators Extra care in ICU Number Percent (%)
Days spent in ICU
≤ 3 245 66.9
>3 121 33.1
Needed NGT
No 346 94.5
Yes 20 5.5
Extra-medication
No 317 86.6
Yes 49 13.4
Physiotherapy
No 352 96.2
Yes 14 3.8
Any extra-care needed
No 234 63.9
Yes 132 36.1
Muganyizi and Shagdara BMC Pregnancy and Childbirth 2011, 11:41
http://www.biomedcentral.com/1471-2393/11/41
Page 5 of 8Table 3 Bivariate and multivariate logistic regression analysis to predict the need for extra care in ICU among
eclamptic patients admitted at Muhimbili National Hospital in 2008
Variable Needed Extra Care: Bivariate Analysis: Multivariate Analysis:
Yes No OR 95% CI OR 95% CI
Type of referral
MNH 6 26 0.9 0.2-3.0 0.3 0.03-3.5
Private hospitals 17 12 5.2 1.6-16.7 3.2 0.7-13.6
District Hospitals 103 174 2.2 0.9-5.5 2.7 0.9-8.7
Home 6 22 1 1
Number of fits
12 6 6 8 1 1
2 40 83 1.3 0.7-2.3 1.3 0.6-2.7
≥3 66 83 2.1 1.2-3.6 1.5 0.8-3.2
State of consciousness
Alert 56 143 1 1
Altered 76 91 2.1 1.4-3.3 2.3 1.3-4.0
Time taken to delivery*
≤12 40 126 1 1
12:01-24.00 35 47 2.3 1.3-4.1 2.0 1.1-3.7
≥24.01 33 10 10.4 4.7-23.0 10.0 4.3-23.6
Mode of delivery
Vaginal 70 151 1 1
Abdominal 62 83 1.6 1.0-2.5 2.5 1.4-4.5
Gestation Age
≤32 weeks 33 30 1 1
33-36 39 64 0.6 0.3-1.0 0.6 0.3-1.3
≥37 40 89 0.4 0.2-0.8 0.5 0.2-1.0
Age group (years)
≤ 19 36 65 1
20-24 50 100 0.9 0.5-1.5
25-29 27 37 1.3 0.7-2.5
≥30 19 32 1.1 0.5-2.2
Parity
0 69 133 1
1-2 51 86 1.1 0.7-1.8
≥3 12 15 1.5 0.7-3.5
Marital status
Single 13 18 1
Married 62 99 1.2 0.5-2.5
Unspecified 57 117 0.8 0.5-1.2
Last Hb level (g/dl)
> 8.5 115 198 1
≤8.5 17 36 0.8 0.4-1-5
Timing of first fit
Antepartum 104 166 1
Intrapartum 8 17 0.8 0.3-1.8
Postpartum 20 51 0.6 0.3-1.1
*Labor details not available in 75 (20.5%) cases
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mothers who were undelivered for more than 24 hours.
These results underscore the need for expedite delivery
of eclamptic mothers at MNH.
The eclampsia case fatality rate of 4.9% in the current
study was close to the previously reported rate of 5.0%-
7.7% at the same hospital [10,11] indicating that there
has not been a significant improvement in the reduction
of maternal mortality due to eclampsia for the past 10
years. Although this case specific fatality seems much
higher than what is reported in the developed countries
such as the 0.4% in Canada[21], it is lower than what is
often reported in some other developing countries
including the 29.5% in India[22], 7.8-39.4% in Nigeria
[13,23-25] and 10.7% in Benin[26]. Moreover, the 4.9%
mortality due to eclampsia is within the internationally
acceptable eclampsia specific maternal mortality of less
than 5% [7,27]. Nevertheless, the variations in maternal
mortality rates due to eclampsia indicate that, there is
room for further reduction of eclampsia related mater-
nal mortality at MNH.
Like other retrospective studies, the current study suf-
fered incompleteness of data in the case records and in
other documents that were used. Thus, some of the
important information such as socioeconomic back-
g r o u n d ,t r e a t m e n td e t a i l s ,t iming of fits at home, and
timing of attendance by the specialists and by others,
details for postpartum eclampsia cases and others were
lacking. Another limitation was related to the sample
size. Since some of the indicators of the need for extra
c a r ei nI C Uw e r en o tv e r yp r e v a l e n t ,t h ea d v e r s ee v e n t s
were few leading to the wide 95% confidence intervals in
some regression analyses. In order to overcome these
problems, a multicenter prospective study is suggested
that will provide a much more detailed data for Tanzania.
Conclusions
In conclusion, the proportion of eclamptic mothers who
need extra care in ICU at MNH is high despite of the
availability of MgSO4 which is currently the gold stan-
dard in controlling eclamptic fits. Ineffective pre-referral
management of eclampsia and the failure to expedite
delivery are the key underlying factors. Future interven-
tions should target community education and improve-
ment of case management at all the referral facilities
including MNH.
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